RENE.U Stock Overview
Does not have significant operations. More details
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 1/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Cartesian Growth Corporation II Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$11.38 |
52 Week High | US$11.70 |
52 Week Low | US$10.92 |
Beta | -0.019 |
11 Month Change | 0% |
3 Month Change | 0.088% |
1 Year Change | 4.21% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 13.57% |
Recent News & Updates
Recent updates
Shareholder Returns
RENE.U | US Capital Markets | US Market | |
---|---|---|---|
7D | 0% | 2.9% | 2.2% |
1Y | 4.2% | 57.5% | 31.7% |
Return vs Industry: RENE.U underperformed the US Capital Markets industry which returned 56.7% over the past year.
Return vs Market: RENE.U underperformed the US Market which returned 31.1% over the past year.
Price Volatility
RENE.U volatility | |
---|---|
RENE.U Average Weekly Movement | n/a |
Capital Markets Industry Average Movement | 3.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.8% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: RENE.U's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine RENE.U's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2021 | n/a | Peter Yu | www.cartesiangrowth.com/cgc2 |
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in New York, New York.
Cartesian Growth Corporation II Fundamentals Summary
RENE.U fundamental statistics | |
---|---|
Market cap | US$151.06m |
Earnings (TTM) | US$9.70m |
Revenue (TTM) | n/a |
15.6x
P/E Ratio0.0x
P/S RatioIs RENE.U overvalued?
See Fair Value and valuation analysisEarnings & Revenue
RENE.U income statement (TTM) | |
---|---|
Revenue | US$0 |
Cost of Revenue | US$0 |
Gross Profit | US$0 |
Other Expenses | -US$9.70m |
Earnings | US$9.70m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 0.75 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | -29.7% |
How did RENE.U perform over the long term?
See historical performance and comparison